Exercise / P53 Cancer Research Results

Ex, Exercise: Click to Expand ⟱
Features: Therapy
Regular physical activity has been shown to influence cancer risk, progression, and survivorship. While exercise is not a cure for cancer, extensive research indicates that it can help reduce the risk of developing certain types of cancer and improve outcomes and quality of life for those diagnosed.

-Lowering the levels of hormones levels.
-Preventing high blood levels of insulin.
-Regular physical activity leads to decreased levels of inflammatory markers (such as C-reactive protein and interleukin-6).
-Improving immune system function (enhancing the circulation of immune cells, including natural killer cells, T lymphocytes, and macrophages)
-Reducing the time it takes for food to travel through the digestive system.
-Helping to prevent obesity, which is a risk factor for many cancers.
-Exercise promotes the upregulation of antioxidant defenses.
Exercise simultaneously modulates multiple core cancer drivers:
  ↓ Insulin / IGF-1 signaling
  ↓ Chronic inflammation (IL-6, TNF-α baseline)
  ↑ Immune surveillance (NK cells, CD8⁺ T cells)
  ↑ Mitochondrial function and mitophagy
  ↓ Estrogen and androgen bioavailability
  ↑ Circadian stability
  ↓ Visceral adiposity (key endocrine organ)
No supplement or single molecule does this breadth of work.

Exercise, fasting, and diet work by changing the environment tumors depend on — not by poisoning the tumor.


Age-stratified interpretation 
1. Younger / metabolically healthy adults
-Baseline IGF-1: normal–high
-Exercise effect:
  -Systemic IGF-1 ↔ or slight ↓
  -IGF-1 signaling efficiency ↑ (better receptor sensitivity)
-Net effect:
  -Less chronic growth drive
  -Better metabolic control
➡ This is where IGF-1 ↓ papers usually come from.

2. Older adults (≈50–60+ years)
-Baseline IGF-1: low
-Exercise effect:
  -IGF-1 ↑ (restoration toward youthful range)
  -Improved GH → IGF-1 axis responsiveness
-Net effect:
  -Muscle, bone, immune maintenance
  -Reduced frailty and inflammation
➡ This is where IGF-1 ↑ papers come from.

3. Cancer relevance (critical distinction)
-Even when circulating IGF-1 increases in older exercisers:
-Tumor IGF-1 signaling still goes DOWN, because:
  -Insulin sensitivity improves
  -IGFBP balance shifts
  -Inflammation drops
  -mTOR tone is suppressed
  -AMPK tone is elevated
So:
-Host IGF-1 ↑ ≠ tumor IGF-1 signaling ↑
Exercise — Cancer vs Normal Cell Effects
Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Insulin / IGF-1 signaling ↓ IGF-1 signaling (tumor context) ↑ or ↓ IGF-1 (age- and baseline-dependent normalization) Driver Growth-signal reprogramming Exercise normalizes IGF-1 toward age-appropriate levels while reducing tumor-promoting signaling
2 AMPK → mTOR nutrient sensing ↑ AMPK; ↓ mTOR (growth restraint) ↑ AMPK; ↓ mTOR (metabolic optimization) Driver Energy-sensing reprogramming Repeated AMPK activation enforces catabolic signaling incompatible with tumor anabolism
3 Immune surveillance (NK cells, T cells) ↑ immune-mediated tumor pressure ↑ immune competence Driver Enhanced antitumor immunity Exercise mobilizes NK cells and improves immune trafficking into tumors
4 Mitochondrial metabolism / metabolic flexibility ↓ metabolic advantage ↑ mitochondrial capacity and flexibility Secondary Energy efficiency divergence Normal cells adapt metabolically; cancer cells lose relative advantage
5 Reactive oxygen species (ROS) ↑ ROS (secondary, transient) ↑ transient ROS → adaptive signaling Secondary Hormetic redox signaling Exercise induces transient ROS that act as signals rather than toxins
6 Glutathione (GSH) and antioxidant capacity ↔ or insufficient upregulation ↑ GSH and antioxidant enzymes Adaptive Redox resilience in normal tissue Normal cells adaptively increase antioxidant defenses; tumors adapt poorly
7 NRF2 antioxidant response ↔ modest activation ↑ NRF2 (adaptive) Adaptive Stress adaptation NRF2 supports recovery and resilience rather than cytotoxicity
8 Inflammatory signaling (NF-κB / cytokines) ↓ pro-tumor inflammation ↓ chronic inflammation Secondary Anti-inflammatory milieu Exercise reduces chronic low-grade inflammation that supports tumor progression
9 Cell cycle / proliferation ↓ proliferation (indirect) ↔ normal turnover Phenotypic Growth restraint Proliferation effects arise from upstream hormonal and metabolic changes


Exercise — Alzheimer’s Disease & Cognitive Decline
Rank Pathway / Axis Direction Label Primary Interpretation Key Cognitive / AD Relevance Notes
1 BDNF / TrkB neurotrophic signaling ↑ BDNF Driver Synaptic plasticity and neuronal survival Improves learning, memory consolidation, and hippocampal resilience BDNF induction is the single most robust and reproducible neurocognitive effect of exercise
2 Neurogenesis (hippocampal dentate gyrus) ↑ neurogenesis Driver Structural cognitive reserve Supports memory formation and delays cognitive decline Adult hippocampal neurogenesis is exercise-responsive and BDNF-dependent
3 Cerebral blood flow / angiogenesis (VEGF) ↑ perfusion Driver Improved nutrient and oxygen delivery Enhances executive function and processing speed Vascular health strongly predicts AD progression
4 Mitochondrial biogenesis (PGC-1α) ↑ mitochondrial capacity Driver Energy resilience in neurons Preserves synaptic function and neuronal firing reliability Mitochondrial dysfunction is an early AD feature
5 Neuroinflammation (microglia, cytokines) ↓ chronic inflammation Driver Microglial normalization Reduces neurotoxic inflammatory signaling linked to cognitive decline Exercise shifts microglia toward a neuroprotective phenotype
6 Insulin signaling / brain glucose utilization ↑ insulin sensitivity Secondary Improved neuronal fuel utilization Supports memory and executive function “Type 3 diabetes” concept in AD makes this pathway central
7 Amyloid-β production & clearance ↓ Aβ burden (modest) Secondary Reduced proteotoxic stress Slows pathological cascade rather than reversing plaques Exercise improves clearance more than production suppression
8 Tau phosphorylation / aggregation ↓ tau pathology (indirect) Secondary Axonal stability preservation Supports memory retention and neuronal transport Effect mediated via inflammation and insulin signaling
9 Oxidative stress / ROS ↓ chronic ROS Adaptive Redox stabilization Protects synapses and mitochondria Transient exercise ROS induces long-term antioxidant adaptation
10 Cognitive performance (memory, executive function) ↑ performance Phenotypic Functional outcome Improved memory, attention, processing speed Emergent result of upstream neurotrophic, vascular, and metabolic effects


P53, P53-Guardian of the Genome: Click to Expand ⟱
Source: TCGA
Type: Proapototic
TP53 is the most commonly mutated gene in human cancer. TP53 is a gene that encodes for the p53 tumor suppressor protein ; TP73 (Chr.1p36.33) and TP63 (Chr.3q28) genes that encode transcription factors p73 and p63, respectively, are TP53 homologous structures.
p53 is a crucial tumor suppressor protein that plays a significant role in regulating the cell cycle, maintaining genomic stability, and preventing tumor formation. It is often referred to as the "guardian of the genome" due to its role in protecting cells from DNA damage and stress.
TP53 gene, which encodes the p53 protein, is one of the most frequently mutated genes in human cancers.
Overexpression of MDM2, an inhibitor of p53, can lead to decreased p53 activity even in the presence of wild-type p53.
In some cancers, particularly those with mutant p53, there may be an overexpression of the p53 protein.
Cancers with overexpression: Breast, lung, colorectal, overian, head and neck, Esophageal, bladder, pancreatic, and liver.
Scientific Papers found: Click to Expand⟱
5055- Ex,    Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes
- Review, Var, NA
OS↑, IGF-1↓, IGFBP3↑, BRCA1↑, BRCA2↑, RAS↓, P53↑, HSPs↑, Leptin↓, Irisin↓, Resistin↓, NK cell↑, CRP↓, IL6↓, TNF-α↓, PGE1↓, COX2↓, *GSH↑, *Catalase↑, *SOD↑, *monoA↑, *EndoR↑, *testos↑, ROS↑, QoL↑, BMD↑, BowelM↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↑, 1,  

Transcription & Epigenetics ⓘ

BowelM↑, 1,  

Protein Folding & ER Stress ⓘ

HSPs↑, 1,  

DNA Damage & Repair ⓘ

BRCA1↑, 1,   BRCA2↑, 1,   P53↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

IGF-1↓, 1,   IGFBP3↑, 1,   RAS↓, 1,  

Immune & Inflammatory Signaling ⓘ

COX2↓, 1,   CRP↓, 1,   IL6↓, 1,   NK cell↑, 1,   PGE1↓, 1,   Resistin↓, 1,   TNF-α↓, 1,  

Hormonal & Nuclear Receptors ⓘ

Irisin↓, 1,   Leptin↓, 1,  

Clinical Biomarkers ⓘ

BMD↑, 1,   BRCA1↑, 1,   CRP↓, 1,   IL6↓, 1,  

Functional Outcomes ⓘ

OS↑, 1,   QoL↑, 1,  
Total Targets: 24

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

Catalase↑, 1,   GSH↑, 1,   SOD↑, 1,  

Synaptic & Neurotransmission ⓘ

EndoR↑, 1,   monoA↑, 1,  

Hormonal & Nuclear Receptors ⓘ

testos↑, 1,  
Total Targets: 6

Scientific Paper Hit Count for: P53, P53-Guardian of the Genome
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:171  Target#:236  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page